BMJ · 1982 · 81 citations · 9 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyNeurologic PharmacotherapyPhotodermatologyNeuromuscular Blocking AgentsVasoactive MedicationsBlood FlowBlood Flow MeasurementSkin Temperature ControlSkin Temperature Measurement
The selective 5-hydroxytryptamine2-(5-HT2)-receptor-blocking agent ketanserin was given in a dose of 10 mg intravenously to nine patients with Raynaud's phenomenon. The effect on blood flow was assessed by photopletysmography and measurments of skin temperature. Digital blood flow and skin temperature increased significantly after ketanserin injection, whereas the placebo (saline 9 g/l) had no such effect. This study suggests that ketanserin may be useful in the treatment of Raynaud's phenomenon.
9
Edgar V. Allen · The American Journal of the Medical Sciences · 1932 · 307 citations
Jan M. Van Nueten, Paul A. J. Janssen, Walter De Ridder et al. · European Journal of Pharmacology · 1982 · 116 citations
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.
G. J. Wenting, A J Man in 't Veld, A. J. J. Woittiez et al. · BMJ · 1982 · 90 citations · Full text
Raynaud's Disease, Raynaud's Phenomenon, and Serotonin
Alfred Halpern, P Kühn, Herbert E. Shaftel et al. · Angiology · 1960 · 88 citations
Medicine, Neurology, Psychiatry +6